Magazine article Phi Kappa Phi Forum

Tulkoff's Class Project: Becomes Innovative Business

Magazine article Phi Kappa Phi Forum

Tulkoff's Class Project: Becomes Innovative Business

Article excerpt

all about shaking things up, she said, perhaps moving the medical field faster than it really wants to go.

"Things move really slow compared to the rest of the electronics world," she said.

Tulkoff s team changed a bit after graduation, but Flipped went on, spending part of 2015 in a business incubator, competing for grants from Dell, and partnering with another local company that made inhalable lung drugs.

"The underlying tech is the same," Tulkoff said, and that company was farther along in the drug-making process than they were, so using their equipment to prove their process and its value was a stroke of luck.

Flipped first focused on the human papillomavirus, or HPV, vaccine, because it was a newer, more expensive vaccine that had yet to spread really beyond the U.S. and Europe, Tulkoff said. They're also working with early childhood diseases, and on diseases in central and South America. But, even with the extra partnerships, they're still years away from a viable product.

Not only do medical tech processes move at a glacial place, they've also had to contend with some unexpected difficulties.

"The vaccine space is heavily politicized," Tulkoff said. "And the humanitarian market has also been a learning curve."

Her membership in Phi Kappa Phi and her $500 award have been a boon. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.